Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Prestige Consumer Healthcare Inc. buy StockNews.com

Start price
€54.50
16.12.23 / 50%
Target price
-
16.12.24
Performance (%)
19.27%
Price
€65.00
25.04.24
Summary
This prediction is currently active. The BUY prediction by StockNews_com currently has a performance of 19.27%. This prediction currently runs until 16.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Prestige Consumer Healthcare Inc. 0.775% 0.775%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by StockNews_com for this prediction

In the thread Prestige Consumer Healthcare Inc. diskutieren

Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat

Stopped prediction by StockNews_com for Prestige Consumer Healthcare Inc.

buy
Prestige Consumer Healthcare Inc.

Start price
Target price
Perf. (%)
€63.00
10.02.24
-
10.02.25
3.17%
25.04.24

buy
Prestige Consumer Healthcare Inc.

Start price
Target price
Perf. (%)
€52.50
24.06.23
-
24.06.24
23.81%
25.04.24